Pipelines

Classification
Disease
Discovery
Pre-clinical
Clinical Trials
Collaborator

RNA & DDS[1]
COVID-19 (Vaccine)
Ongoing Phase 2a
Cancer (Vaccine)
DDS (LNP)
EYEGENE

NCE[2]
Blood Cancer(AML[3])
Solid Tumor
(Glioblastoma)
Blood anticoagulant (NOAC[4])
Autism (ASD[5])
Solid Tumor
(ovatian cancer, prostate cancer)
Solid Tumor
(Cancer immunotherapy)
KRICT, KIRAMS, KAIST and SEVERANCE HOSPITAL, UNC, NeuroVenti, Seoul national University Bundang Hospital
KRICT, KIRAMS, KAIST and SEVERANCE HOSPITAL, UNC, NeuroVenti, Seoul national University Bundang Hospital, Redipharm, KYNOGEN
Redipharm
KYNOGEN

PROTAC[6]
Cancer

SaaS[7]
ADME/T
Newly started
(1) DDS (Drug Delivery System) (2) NCE (New Chemical Entity) (3) AML (Acute Myeloid Leukemia) (4) NOAC (New Oral Anticoagulant ) (5) ASD (Autism Spectrum Disorder) (6) PROTAC (PROteolysis Targeting Chimeras) (7) SaaS (Software as a Service)